Names

jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has named Gordon Brooks as its interim chief financial officer, effective July 15, 2024. Brooks has held various leadership roles during his 29-year career with the company, and currently serves as group VP, controller and corporate strategy. He will replace Anat Ashkenazi,Continue Reading

vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) named Robert A. Michael as the CEO and joined AbbVie’s Board of Directors, effective today. Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company’s inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.Continue Reading